The invention relates to processes for manufacturing a compound of formula 5,or a stereoisomer, tautomer or a salt thereof, wherein the substituents are as defined in the specification. The invention further relates to new manufacturing processes for specific solid forms of Compound A and its salts, to such solid forms and to use of said solid forms for the therapeutic treatment of warm-blooded animals.本發明係關於製造式5化合物,或其立體異構體、互變異構體或鹽之方法,其中取代基如說明書中所定義。本發明另外關於化合物A及其鹽的特定固體形式之新穎製造方法、該等固體形式及該等固體形式用於治療性處理溫血動物之用途。